May 14, 2020 / 03:30PM GMT
Operator
Good morning. My name is Colin, and I will be your conference operator today. At this time, I would like to welcome everyone to InMed's Third Quarter Fiscal Year 2020 Financial Results and Business Update Conference Call for the period ending March 31, 2020. (Operator Instructions)
Thank you. Mr. Payne, you may begin your conference.
Brendan Payne - InMed Pharmaceuticals Inc. - Director of IR
Thank you, Colin. And good day, ladies and gentlemen. My name is Brendan Payne, InMed's Director of Investor Relations, and welcome to InMed's Third Quarter Fiscal Year 2020 Financial Results and Business Update Conference Call. Please note, our speakers are joining us from separate locations at a safe distance, so we appreciate your patience if we encounter any unexpected technical challenges.
Before we begin, we'd like to go over our disclosure statements, followed by a review of the progress on our therapeutic development in cannabinoid manufacturing programs, which will be led by our President and CEO, Eric Adams. Mr. Bruce Colwill, our Chief
Q3 2020 InMed Pharmaceuticals Inc Earnings Call Transcript
Mar 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers